Quantcast

Latest Hematology Stories

2014-07-02 12:15:29

The JAMA Network Journals In patients with a traumatic brain injury (TBI), neither the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin concentration through blood transfusion resulted in improved neurological outcome at 6 months, according to a study in the July 2 issue of JAMA. Transfusing at higher hemoglobin concentrations was associated with a higher risk of adverse events. Patients with severe traumatic brain injury commonly develop anemia....

2014-07-02 12:12:20

The JAMA Network Journals Use of a lower intensity bone marrow transplantation method showed promising results among 30 patients (16-65 years of age) with severe sickle cell disease, according to a study in the July 2 issue of JAMA. Myeloablative (use of high-dose chemotherapy or radiation) allogeneic hematopoietic stem cell transplantation (HSCT; receipt of hematopoietic stem cells "bone marrow" from another individual) is curative for children with severe sickle cell disease, but...

2014-07-02 08:26:14

BOCA RATON, Fla., July 2, 2014 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at 311 North Patterson Road, in Valdosta, Georgia. The almost 16,000 square foot state-of-the-art facility officially opened its doors for business on June 30(th) 2014 and brings the total number of BPC's plasma collection centers to sixteen. "This...

2014-07-01 08:29:55

Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer THOUSAND OAKS, Calif., July 1, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to investigational bispecific T cell engager (BiTE(®)) antibody blinatumomab, for adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL), a rapidly...

2014-06-27 12:26:33

Study published in Clinical Cancer Research and co-led by Adaptive Biotechnologies and the University of Washington demonstrates clinical utility of Next Generation Immune Profiling SEATTLE, June 27, 2014 /PRNewswire/ -- Adaptive Biotechnologies today announced results demonstrating enhanced accuracy and sensitivity of clonoSEQ in identifying risk of relapse in patients with B-cell Acute Lymphoblastic Leukemia (B-ALL), a childhood leukemia, compared to flow cytometry, the current...

2014-06-24 23:02:48

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) June 24, 2014 The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of new litigation news on the site. Recent court records show there are still nearly 9,000 lawsuits pending that allege side effects from the drugs*. DrugNews was created for patients taking...

2014-06-24 08:30:22

FDA now requires general product label warnings about increased risk ALTON, Ill., June 24, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) announced late last week there has been another risk linked to testosterone treatments. The FDA now requires manufacturers of testosterone or low-T products to add a general label warning about the increased risk for blood clots in veins to their prescription testosterone treatments. Blood clots in the veins, also known as venous...

2014-06-23 23:02:26

The Firm is evaluating testosterone treatment lawsuits on behalf of men who may have suffered life-threatening cardiovascular injuries, including heart attacks, strokes and blood clots, due to low testosterone therapy. New York, NY (PRWEB) June 23, 2014 As testosterone lawsuit (http://www.testosteronelawsuitclaims.com/) filings continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the Food & Drug Administration (FDA) is warning of a potential risk for venous blood clots...

FDA Orders Testosterone Supplement Makers To Include Blood Clot Warnings
2014-06-22 08:51:08

redOrbit Staff & Wire Reports – Your Universe Online The US Food and Drug Administration (FDA) is now requiring manufacturers of testosterone supplements to include a general warning label about the risk of blood clots in the veins, various media outlets reported on Friday. While testosterone products already carry warning labels pertaining to a risk of clots associated with polycythemia, which involved an abnormal increase in red blood cells after use of such supplements, Reuters...

2014-06-20 08:23:38

RIDGEFIELD, Conn., June 20, 2014 /PRNewswire/ -- Boehringer Ingelheim announced today the initiation of a new international study of Pradaxa® (dabigatran etexilate mesylate). The RE-CIRCUIT(TM) trial (Randomized Evaluation of dabigatran etexilate Compared to warfarIn in pulmonaRy vein ablation: assessment of different peri-proCedUral antIcoagulation sTrategies) will evaluate uninterrupted treatment with PRADAXA, compared to warfarin, in patients with paroxysmal or persistent non-valvular...


Latest Hematology Reference Libraries

2012-06-14 04:12:14

Symbol: ZYGOP2 Group: Fern Family: Grammitidaceae Distribution: ZygophlebiaBishop distribution:USA+(PR) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Division   Pteridophyta – Ferns Class   Filicopsida Order   Polypodiales Family   Grammitidaceae – Kihi Fern family Genus   Zygophlebia Bishop – octopus fern

2012-06-14 07:28:41

Symbol: ZATH Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylumthomasianum(Krug & Urb.) Krug & Urb. ex P. Wilson distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta –...

2012-06-14 07:28:42

Symbol: ZASP Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylumspinifex(Jacq.) DC. distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

2012-06-14 07:28:48

Symbol: ZAPU2 Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: ZanthoxylumpunctatumVahl distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

2012-06-14 07:28:50

Symbol: ZAMO Group: Dicot Family: Rutaceae Duration: Perennial Growth Habit: Tree Shrub Native Status: PR    N VI    N Distribution: Zanthoxylummonophyllum(Lam.) P. Wilson distribution:USA+(PR, VI) Classification:       Kingdom   Plantae – Plants Subkingdom   Tracheobionta – Vascular plants Superdivision   Spermatophyta – Seed plants Division   Magnoliophyta – Flowering plants Class  ...

More Articles (1280 articles) »
Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related